THE ROLE OF NONINVASIVE VENTILATION AND HIGH-FLOW NASAL CANNULA IN CRITICAL COVID-19 PNEUMONIA

ABSTRACT

139 (29.1%) underwent delaying intubation with HFNC/NIV with a median time to intubation of 2.9 (IQR,0.78-6.16) days, longer compared with the non-intervention group, 0.42 (IQR, 0.11-2.0) days. Kaplan Meier analysis was conducted to determine survival rate and Cox Proportional Hazard regression to determine mortality risk associated with delaying intubation. B Introduction/Hypothesis: b We aimed to determine the mortality risk associated with delaying intubation with High Flow Nasal Cannula (HFNC) and Non-invasive ventilation (NIV) in the setting of critical COVID-19 pneumonia patients that required mechanical ventilation. [Extracted from the article] Copyright of Critical Care Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)